Abstract:Background: Telocytes (TCs) are experimentally evidenced as an alternative of cell therapies for organ tissue injury and repair. The aims of the present studies are to explore direct roles of TCs and the roles of TC-derived exosomes in support of experimental acute lung injury (ALI) in vivo or in vitro. Materials and methods: The roles of TCs in experimental ALI were firstly estimated. Phosphoinositide 3-kinase (PI3K) p110δ and α/δ/β isoform inhibitors were used in study dynamic alterations of bio-behaviors, and in expression of functional factors of TCs per se and TC-co-cultured airway epithelial cells during the activation with lipopolysaccharide (LPS). TC-driven exosomes were furthermore characterized for intercellular communication by which activated or non-activated TCs interacted with epithelia. Results: Our results showed that TCs mainly prevented from lung tissue edema and hemorrhage and decreased the levels of VEGF-A and MMP9 induced by LPS. Treatment with CAL101 (PI3K p110δ inhibitor) and LY294002 (PI3Kα/δ/β inhibitor) could inhibit TC movement and differentiation and increase the number of dead TCs. The expression of Mtor, Hif1α, Vegf-a, or Mmp9 mRNA increased in TCs challenged with LPS, while Mtor, Hif1α, and Vegf-a even more increased after adding CAL101 or Mtor after adding LY. The rate of epithelial cell proliferation was higher in co-culture of human bronchial epithelial (HBE) and TCs than that in HBE alone under conditions with or without LPS challenge or when cells were treated with LPS and CAL101 or LY294002. The levels of mTOR, HIF1α, or VEGF-A significantly increased in mono-cultured or co-cultured cells, challenged with LPS as compared with those with vehicle. LPS-pretreated TC-derived exosomes upregulated the expression of AKT, p-AKT, HIF1α, and VEGF-A protein of HBE. Conclusion: The present study demonstrated that intraperitoneal administration of TCs ameliorated the severity of lung tissue edema accompanied by elevated expression of VEGF-A. TCs could nourish airway epithelial cells through nutrients produced from TCs, increasing epithelial cell proliferation, and differentiation as well as cell sensitivity to LPS challenge and PI3K p110δ and α/δ/β inhibitors, partially through exosomes released from TCs.

Roles of Telocytes in the Development of Angiogenesis.

Potential Significance of Telocytes in the Pathogenesis of Lung Diseases

Potential Roles of Telocytes in Lung Diseases

Telocytes and Lung Disease.

Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro

Telocyte Morphologies and Potential Roles in Diseases

Telocytes play a key role in prostate tissue organisation during the gland morphogenesis

[Location of telocytes in mouse bronchial and pulmonary tissues].

Telocytes in Trachea and Lungs

CD34+ stromal cells/telocytes and their role in mouse lung development: Light microscopy, immunofluorescence, ultrastructural and scanning electron microscopy evidence

Paracrine Endocrinology of Cardiac Telocytes in Culture

Telocytes: current methods of research, challenges and future perspectives

Genetic Comparison of Mouse Lung Telocytes with Mesenchymal Stem Cells and Fibroblasts

Single‐cell RNA Sequencing Reveals Telocytes Subsets of Human Lung

The History of Telocyte Discovery and Understanding.

Vascular Telocytes.

Protein Profiling of Human Lung Telocytes and Microvascular Endothelial Cells Using Itraq Quantitative Proteomics.

Telocytes in human oesophagus.

Roles of telocytes dominated cell-cell communication in fibroproliferative acute respiratory distress syndrome

Influence of Gene Modification in Biological Behaviors and Responses of Mouse Lung Telocytes to Inflammation

Roles of pulmonary telocytes in airway epithelia to benefit experimental acute lung injury through production of telocyte-driven mediators and exosomes